BRIEF RESEARCH REPORT article

Front. Neurol.

Sec. Neurological Biomarkers

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1566228

Exploring Tau-C, Tau-A and C1M as Biomarkers for Parkinson's Disease

Provisionally accepted
  • 1Research fellow, København Nv, Denmark
  • 2Directory of endocrinology, København Nv, Denmark
  • 3CEO, København Nv, Denmark
  • 4Scientific director -Immunoscience, København Nv, Denmark

The final, formatted version of the article will be published soon.

Tau has shown to be associated with neurodegenerative diseases. In this exploratory study, we investigated the utility of blood-based biomarkers measuring Tau-C, Tau-A and C1M in Parkinson's disease (PD) to explore their potential as diagnostic biomarkers in two independent cohorts (TAU-C, TAU-A). We found them to discriminate between healthy donors and PD individuals (all p<0.001), with Tau-C showing the best diagnostic discrepancy (AUROC = 0.97). Therefore, Tau-C, Tau-A and C1M may be biomarkers for PD diagnosis.

Keywords: biomarker, Parkinson's disease, Tau-C, Tau-A, C1M

Received: 24 Jan 2025; Accepted: 08 Apr 2025.

Copyright: © 2025 Benmarce, Henriksen, Karsdal and Holm Nielsen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Meryem Benmarce, Research fellow, København Nv, Denmark

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more